Fund: FTBDFEH
| Franklin Templeton - Franklin Biotechnology Discovery Fund A (acc) EUR-H1 | |
| LU1803069274 | |
| 06-04-2018 | |
| Equity | |
| Equity Sectors - Health Care | |
| Franklin Templeton Investment Funds | |
| Franklin Advisers, Inc. | |
| Evan McCulloch | |
| EUR | |
| 100 | |
| 5.75% |
| 1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Výkonnosť fondu | -8.73% | -2.84% | 22.58% | 12.79% | 11.12% | -5.62% | 3.00% | - | - | N/A | |
| Priemerná výkonnosť (36 meraní) | -0.04% | -5.11% | - | - | - | ||||||
| Volatilita od priemernej výkonnosti | 9.24% | 28.61% | - | - | - |
| Long | Short | Net | |
|---|---|---|---|
| Stock | 96.90% | 96.90% | |
| Bond | |||
| Other | 0.61% | 0.61% | |
| Cash | 2.49% | 2.49% |
| Aktíva | 135 mil. |
| Počet akcíí | 93 |
| Počet dlhopisov | 0 |
| Priebež. popl. | 1.81 |
| z toho Mng. popl. | 1.50 |
| Výk. prémia | |
| Trans. popl. | 0.09 |
| Dividenda | |
| Dividendový výnos | |
| Rozhodný dátum | |
| Frekvencia výplaty |
| Giant | 2.75% |
| Large | 22.36% |
| Medium | 19.43% |
| Small | 15.58% |
| Micro | 32.33% |
| P/E | 16.58% |
| P/BV | 4.29% |
| Basic Materials | 1.29% |
| Healthcare | 91.22% |
| Corporate | 0.53 |
| Derivatives | 2.49 |
| Výnos do splatnosti p.a. | |
| Modifikovaná durácia |
| AAA | 0.00 |
| AA | 0.00 |
| A | 0.00 |
| BBB | 0.00 |
| BB | 0.00 |
| B | 0.00 |
| Below B | 0.00 |
| Not Rated | 100.00 |
| United States | 84.51% |
| Canada | 1.03% |
| Latin America | |
| United Kingdom | 3.61% |
| Eurozone | 3.77% |
| Europe - ex Euro | 3.99% |
| Europe - Emerging | |
| Africa | |
| Middle East | |
| Japan | |
| Australasia | |
| Asia - Developed | |
| Asia - Emerging | |
| Emerging Market | |
| Developed Country | 96.90% |
| Not Classified |
| Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
|---|---|---|---|---|---|
| Amgen Inc | Healthcare | 6.58% | Regeneron Pharmaceuticals Inc | Healthcare | 6.24% |
| Vertex Pharmaceuticals Inc | Healthcare | 5.2% | Ascendis Pharma A/S ADR | Healthcare | 3.99% |
| Gilead Sciences Inc | Healthcare | 2.92% | Intra-Cellular Therapies Inc | Healthcare | 2.81% |
| Biogen Inc | Healthcare | 2.8% | AstraZeneca PLC ADR | Healthcare | 2.75% |
| Jazz Pharmaceuticals PLC | Healthcare | 2.55% | Merus NV | Healthcare | 2.35% |